Clinical epidemiology of primary biliary cirrhosis

Incidence, prevalence, and impact of therapy

Konstantinos N Lazaridis, Jayant A. Talwalkar

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease of unknown etiology. It is typically characterized by a trio of criteria including cholestatic liver biochemistry tests for at least 6 month's duration, the presence of a positive serum antimitochondrial antibody, and histologic findings from liver biopsy that are compatible or diagnostic with PBC. Although no unifying mechanism of action has been described to explain the pathogenesis of PBC to date, the natural history of this condition is greatly influenced by several known and unknown risk factors. In turn, a number of publications have focused on describing the burden of disease and prognosis in patients with PBC, This review article will summarize the descriptive epidemiology of PBC including new insights on risk factors, prognosis, and the effect of medical therapy in contemporary patients.

Original languageEnglish (US)
Pages (from-to)494-500
Number of pages7
JournalJournal of Clinical Gastroenterology
Volume41
Issue number5
DOIs
StatePublished - May 2007

Fingerprint

Biliary Liver Cirrhosis
Epidemiology
Incidence
Therapeutics
Liver
Natural History
Biochemistry
Publications
Liver Diseases
Biopsy
Antibodies
Serum

Keywords

  • Biliary cirrhosis
  • Epidemiology
  • Natural history

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Clinical epidemiology of primary biliary cirrhosis : Incidence, prevalence, and impact of therapy. / Lazaridis, Konstantinos N; Talwalkar, Jayant A.

In: Journal of Clinical Gastroenterology, Vol. 41, No. 5, 05.2007, p. 494-500.

Research output: Contribution to journalArticle

@article{e093fbf07b7943e187cc8a27802ebb62,
title = "Clinical epidemiology of primary biliary cirrhosis: Incidence, prevalence, and impact of therapy",
abstract = "Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease of unknown etiology. It is typically characterized by a trio of criteria including cholestatic liver biochemistry tests for at least 6 month's duration, the presence of a positive serum antimitochondrial antibody, and histologic findings from liver biopsy that are compatible or diagnostic with PBC. Although no unifying mechanism of action has been described to explain the pathogenesis of PBC to date, the natural history of this condition is greatly influenced by several known and unknown risk factors. In turn, a number of publications have focused on describing the burden of disease and prognosis in patients with PBC, This review article will summarize the descriptive epidemiology of PBC including new insights on risk factors, prognosis, and the effect of medical therapy in contemporary patients.",
keywords = "Biliary cirrhosis, Epidemiology, Natural history",
author = "Lazaridis, {Konstantinos N} and Talwalkar, {Jayant A.}",
year = "2007",
month = "5",
doi = "10.1097/01.mcg.0000225653.07932.8f",
language = "English (US)",
volume = "41",
pages = "494--500",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Clinical epidemiology of primary biliary cirrhosis

T2 - Incidence, prevalence, and impact of therapy

AU - Lazaridis, Konstantinos N

AU - Talwalkar, Jayant A.

PY - 2007/5

Y1 - 2007/5

N2 - Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease of unknown etiology. It is typically characterized by a trio of criteria including cholestatic liver biochemistry tests for at least 6 month's duration, the presence of a positive serum antimitochondrial antibody, and histologic findings from liver biopsy that are compatible or diagnostic with PBC. Although no unifying mechanism of action has been described to explain the pathogenesis of PBC to date, the natural history of this condition is greatly influenced by several known and unknown risk factors. In turn, a number of publications have focused on describing the burden of disease and prognosis in patients with PBC, This review article will summarize the descriptive epidemiology of PBC including new insights on risk factors, prognosis, and the effect of medical therapy in contemporary patients.

AB - Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease of unknown etiology. It is typically characterized by a trio of criteria including cholestatic liver biochemistry tests for at least 6 month's duration, the presence of a positive serum antimitochondrial antibody, and histologic findings from liver biopsy that are compatible or diagnostic with PBC. Although no unifying mechanism of action has been described to explain the pathogenesis of PBC to date, the natural history of this condition is greatly influenced by several known and unknown risk factors. In turn, a number of publications have focused on describing the burden of disease and prognosis in patients with PBC, This review article will summarize the descriptive epidemiology of PBC including new insights on risk factors, prognosis, and the effect of medical therapy in contemporary patients.

KW - Biliary cirrhosis

KW - Epidemiology

KW - Natural history

UR - http://www.scopus.com/inward/record.url?scp=34247401795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247401795&partnerID=8YFLogxK

U2 - 10.1097/01.mcg.0000225653.07932.8f

DO - 10.1097/01.mcg.0000225653.07932.8f

M3 - Article

VL - 41

SP - 494

EP - 500

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 5

ER -